Rhizopus - 49288-0435-1 - (Rhizopus)

Alphabetical Index


Drug Information of Rhizopus

Product NDC: 49288-0435
Proprietary Name: Rhizopus
Non Proprietary Name: Rhizopus
Active Ingredient(s): .05    g/mL & nbsp;   Rhizopus
Administration Route(s): INTRADERMAL; SUBCUTANEOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Rhizopus

Product NDC: 49288-0435
Labeler Name: Antigen Laboratories, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: BLA102223
Marketing Category: BLA
Start Marketing Date: 19740323

Package Information of Rhizopus

Package NDC: 49288-0435-1
Package Description: 2 mL in 1 VIAL, MULTI-DOSE (49288-0435-1)

NDC Information of Rhizopus

NDC Code 49288-0435-1
Proprietary Name Rhizopus
Package Description 2 mL in 1 VIAL, MULTI-DOSE (49288-0435-1)
Product NDC 49288-0435
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Rhizopus
Dosage Form Name INJECTION, SOLUTION
Route Name INTRADERMAL; SUBCUTANEOUS
Start Marketing Date 19740323
Marketing Category Name BLA
Labeler Name Antigen Laboratories, Inc.
Substance Name RHIZOPUS STOLONIFER
Strength Number .05
Strength Unit g/mL
Pharmaceutical Classes Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient]

Complete Information of Rhizopus


General Information